Reaching Those At Risk: A Look at Socioeconomics and Retinal Care

Reaching Those At Risk A Look at Socioeconomics and Retinal Care
Media formats available:
Details
Presenters
  • Overview

    This archived satellite symposium covers timely issues about race and socioeconomics and how they impact patient care. The panel discusses access to care and disease awareness among patients with the highest risk factors, as well as barriers to treatment, including patient noncompliance.

    The panel members also share their experience with these issues and potential solutions through case studies and discussions with audience members. 

    This program is not affiliated with the official program of AAO 2021.

    Supported by an independent medical education grant from Regeneron Pharmaceuticals. 

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Discuss how ethnicity and socioeconomics impacts patient awareness of the ocular complications of diabetes
    • Explain the efficacy of current treatment options in specific populations
    • Develop individualized plans for patients with diabetic eye disease who may be at higher risk for progression due to nonadherence
    • Apply case study examples to clinical settings
    • Accreditation

      Provided by Evolve Medical Education

      Accreditation Statement
      Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      Credit Designation Statement
      Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Successful completion of this CME activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirement[s] for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Ankoor R. Shah, MD

      Ankoor R. Shah, MD

      Program Chair
      Retina Consultants of Texas
      Houston, TX


      Nancy Holekamp, MD

      Nancy Holekamp, MD

      Director of Retina Services
      Pepose Vision Institute
      Chesterfield, MO


      Basil K. Williams Jr, MD

      Basil K. Williams Jr, MD

      Assistant Professor of Ophthalmology
      Director of Ocular Oncology
      University of Cincinnati
      Vitreoretinal Surgeon
      Cincinnati Eye Institute


      Yoshihiro Yonekawa, MD

      Yoshihiro Yonekawa, MD

      Adult and Pediatric Vitreoretinal Surgery
      Mid Atlantic Retina
      Wills Eye Hospital
      Philadelphia, PA


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Ankoor R. Shah, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Novartis and Ocular Therapeutix.

      Nancy Holekamp, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis, Bayer, Lineage Cell Therapeutics, Clearside Biosciences, Gemini, Gyroscope, Katalyst Surgical, Nacuity, Notal Vision, Novartis, Polyactiva,  and Regeneron Pharmaceuticals. Grant/Research Support: Genentech, Gemini, Gyroscope, Notal Vision. Speaker's Bureau: Allergan, Genentech, Novartis, Regeneron Pharmaceuticals, and Spark Therapeutics. Shareholder: Katalyst Surgical.

      Basil K. Williams Jr, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Castle Biosciences and Genentech. 

      Yoshihiro Yonekawa, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Alimera, Allergan, and Genentech. 

      The Evolve staff, planners, and reviewers have no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Regeneron Pharmaceuticals.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free